Bayer revenue was €43.55 b in FY, 2019 which is a (10.0%) year over year increase from the previous period.
Bayer revenue breakdown by business segment: 12.5% from Consumer Health, 41.2% from Pharmaceuticals, 45.5% from CropScience and 0.7% from Other
Bayer revenue breakdown by geographic segment: 15.3% from Latin America, 19.8% from Asia / Pacific, 34.6% from North America and 30.3% from Europe / Middle East / Africa
|FY, 2019||FY, 2018||FY, 2017||FY, 2016|
|CropScience||€19.83 b||€14.27 b||€9.58 b||€9.95 b|
|Pharmaceuticals||€17.96 b||€16.75 b||€16.85 b||€16.45 b|
|Animal Health||€1.5 b||€1.57 b||€1.53 b|
|Consumer Health||€5.46 b||€5.45 b||€5.86 b||€6.04 b|
|Other||€277 m||€1.14 b||€3.17 b|
|Corporate Functions and Consolidation||€12 m||€16 m|
|FY, 2019||FY, 2018||FY, 2017|
|Europe / Middle East / Africa||€13.18 b||€14.14 b||€13.39 b|
|North America||€15.09 b||€11.57 b||€10.14 b|
|Asia / Pacific||€8.61 b||€8.12 b||€7.64 b|
|Latin America||€6.66 b||€5.76 b||€3.85 b|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.